Related Experiment Video
Updated: Apr 8, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
[Drug repurposing requires a strategic approach].
Michelle W J Heijman1,2, Calin Popa3, Bart J F van den Bemt4
1Sint Maartenskliniek, Nijmegen. Afd. Research.
Nederlands Tijdschrift Voor Geneeskunde
|April 7, 2026
Summary
Drug repurposing offers a cost-effective path to new therapies by leveraging existing drug knowledge. A clear strategy for candidate selection, data utilization, and stakeholder involvement is crucial for overcoming practical challenges in drug development.
Area of Science:
- Pharmacology
- Drug Development
- Translational Medicine
Background:
- Drug repurposing accelerates therapy development by utilizing drugs with known safety and efficacy profiles.
- Existing preclinical and clinical data reduce the time and cost associated with bringing new treatments to patients.
Purpose of the Study:
- To outline a strategic framework for successful drug repurposing initiatives.
- To identify key considerations for overcoming practical challenges in repurposing existing drugs for new therapeutic indications.
Main Methods:
- The study reviews the rationale and challenges of drug repurposing.
- It proposes a strategic approach encompassing drug selection, data management, and clinical implementation.
Main Results:
- Drug repurposing is a viable strategy but faces practical hurdles.
- A structured approach is essential for successful implementation.
Conclusions:
- Successful drug repurposing requires careful drug candidate selection.
- Efficient use of existing data and early stakeholder engagement are critical for clinical translation.
Related Concept Videos
01:26Drug Discovery: Overview
13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
01:28Structure-Activity Relationships and Drug Design
2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K
01:30Prodrugs
4.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.7K
01:28Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
357
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
357
01:29Pharmacogenomics: Identification of New Drug Targets
88
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88